Alfavision Overseas (India) Limited (ALFAVIO.BO)
INR 12.3
(1.74%)
INR 12.3
(1.74%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.35 Billion INR | -13.38% |
| 2022 | 1.56 Billion INR | 9.95% |
| 2021 | 1.42 Billion INR | 160.91% |
| 2020 | 545.16 Million INR | 12.22% |
| 2019 | 485.79 Million INR | 67.74% |
| 2018 | 289.6 Million INR | 18.86% |
| 2017 | 243.66 Million INR | 350.27% |
| 2016 | 54.11 Million INR | 160.02% |
| 2015 | 20.81 Million INR | -42.41% |
| 2014 | 36.13 Million INR | 10.9% |
| 2013 | 32.58 Million INR | 3.08% |
| 2012 | 31.6 Million INR | 93.14% |
| 2011 | 16.36 Million INR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.24 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 1.35 Billion INR | 0.0% |
| 2023 FY | 1.35 Billion INR | -13.38% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 1.56 Billion INR | 9.95% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 1.56 Billion INR | 0.0% |
| 2022 Q2 | 1.3 Billion INR | 0.0% |
| 2021 Q2 | 769.72 Million INR | 0.0% |
| 2021 FY | 1.42 Billion INR | 160.91% |
| 2021 Q4 | 1.42 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q2 | 533.07 Million INR | 0.0% |
| 2020 FY | 545.16 Million INR | 12.22% |
| 2020 Q4 | 545.11 Million INR | 0.0% |
| 2019 Q2 | 236.62 Million INR | 0.0% |
| 2019 FY | 485.79 Million INR | 67.74% |
| 2019 Q4 | 485.79 Million INR | 0.0% |
| 2018 Q4 | 289.6 Million INR | 0.0% |
| 2018 Q2 | 247.34 Million INR | 0.0% |
| 2018 FY | 289.6 Million INR | 18.86% |
| 2017 Q3 | 199.63 Million INR | 286.18% |
| 2017 Q2 | 51.69 Million INR | -12.45% |
| 2017 Q1 | 59.04 Million INR | 9.11% |
| 2017 FY | 243.66 Million INR | 350.27% |
| 2017 Q4 | 243.66 Million INR | 22.05% |
| 2016 FY | 54.11 Million INR | 160.02% |
| 2016 Q4 | 54.11 Million INR | -23.17% |
| 2016 Q3 | 70.43 Million INR | 36.0% |
| 2016 Q2 | 51.79 Million INR | 96.22% |
| 2016 Q1 | 26.39 Million INR | 26.83% |
| 2015 Q2 | 36.32 Million INR | -2.44% |
| 2015 FY | 20.81 Million INR | -42.41% |
| 2015 Q1 | 37.23 Million INR | 3.04% |
| 2015 Q4 | 20.81 Million INR | -43.79% |
| 2015 Q3 | 37.02 Million INR | 1.93% |
| 2014 Q1 | 26.9 Million INR | -17.44% |
| 2014 FY | 36.13 Million INR | 10.9% |
| 2014 Q4 | 36.13 Million INR | 30.27% |
| 2014 Q3 | 27.73 Million INR | 2.75% |
| 2014 Q2 | 26.99 Million INR | 0.36% |
| 2013 Q3 | 33.1 Million INR | 5.53% |
| 2013 Q4 | 32.58 Million INR | -1.58% |
| 2013 Q1 | 31.95 Million INR | 1.08% |
| 2013 FY | 32.58 Million INR | 3.08% |
| 2013 Q2 | 31.36 Million INR | -1.82% |
| 2012 FY | 31.6 Million INR | 93.14% |
| 2012 Q4 | 31.6 Million INR | -55.17% |
| 2012 Q3 | 70.51 Million INR | 0.0% |
| 2011 FY | 16.36 Million INR | 0.0% |
| 2011 Q4 | 24.94 Million INR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Biocon Limited | 140.18 Billion INR | 99.034% |
| Blue Jet Healthcare Limited | -830.93 Million INR | 263.045% |
| Concord Biotech Limited | -372.86 Million INR | 463.342% |
| Dishman Carbogen Amcis Limited | 18.99 Billion INR | 92.867% |
| FERMENTA BIOTECH LIMITED | 1.1 Billion INR | -22.669% |
| GENOMIC VALLEY BIOTECH LIMITED | -60.73 Thousand INR | 2230787.918% |
| Lyka Labs Limited | 527.01 Million INR | -157.069% |
| Panacea Biotec Limited | -1.18 Billion INR | 214.338% |
| SAMSRITA LABS LIMITED | 21.98 Million INR | -6061.12% |
| Servoteach Industries Limited | 5016.00 INR | -27009190.271% |
| SMS Lifesciences India Limited | 992.31 Million INR | -36.528% |
| Supriya Lifescience Limited | -694.68 Million INR | 295.023% |
| Syngene International Limited | -83 Million INR | 1732.272% |
| TAKE Solutions Limited | 361.37 Million INR | -274.903% |
| Titan Biotech Limited | 54.62 Million INR | -2380.021% |
| Transgene Biotek Limited | 139.93 Million INR | -868.168% |
| Vanta Bioscience Limited | 607.93 Million INR | -122.852% |